ANTX – an2 therapeutics, inc. (US:NASDAQ)
Stock Stats
News
Anthem (ANTX) is now covered by Weiss Ratings. They set a "sell (d-)" rating on the stock.
AN2 Therapeutics Announces Initiation of Phase 2 Investigator-Initiated Clinical Trial of Epetraborole for Mycobacterium abscessus Complex Lung Disease [Yahoo! Finance]
AN2 Therapeutics Announces Initiation of Phase 2 Investigator-Initiated Clinical Trial of Epetraborole for Mycobacterium abscessus Complex Lung Disease
AN2 Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Business and Scientific Highlights [Yahoo! Finance]
AN2 Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Business and Scientific Highlights
Form S-3 AN2 Therapeutics, Inc.
Form 8-K AN2 Therapeutics, Inc. For: Apr 09
Form D AN2 Therapeutics, Inc.
Form 4 AN2 Therapeutics, Inc. For: Mar 19 Filed by: Day Lucy
Form 4 AN2 Therapeutics, Inc. For: Mar 19 Filed by: Chanda Sanjay
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.